{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:54:17Z","timestamp":1784804057489,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NINDS R21 NS097945"],"award-info":[{"award-number":["NINDS R21 NS097945"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIA R01 AG054533"],"award-info":[{"award-number":["NIA R01 AG054533"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NINDS P30 NS069375"],"award-info":[{"award-number":["NINDS P30 NS069375"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.nbd.2020.105089","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T22:33:24Z","timestamp":1600727604000},"page":"105089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer's Disease"],"prefix":"10.1016","volume":"146","author":[{"given":"Andrew K.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooneh M.","family":"Ardestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bitna","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heui Hye","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-1755","authenticated-orcid":false,"given":"Mehrdad","family":"Shamloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.105089_bb0005","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1126\/science.aan6747","article-title":"Thirst-associated preoptic neurons encode an aversive motivational drive","volume":"357","author":"Allen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.nbd.2020.105089_bb0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41586-019-00857-9","article-title":"Scientists rise up against statistical significance","volume":"567","author":"Amrhein","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.105089_bb0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neuropharm.2017.01.010","article-title":"Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer\u2019s disease using a biased and selective beta-1 adrenergic receptor partial agonist","volume":"116","author":"Ardestani","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2020.105089_bb0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","article-title":"The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors","volume":"144","author":"Baker","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2020.105089_bb0025","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1476-5381.2010.00754.x","article-title":"The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors","volume":"160","author":"Baker","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2020.105089_bb0030","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.neurobiolaging.2014.06.011","article-title":"Administration of a selective beta2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer\u2019s disease","volume":"35","author":"Branca","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.105089_bb0035","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40261-019-00830-4","article-title":"Comprehensive real-world assessment of marketed medications to guide Parkinson\u2019s drug discovery","volume":"39","author":"Cepeda","year":"2019","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.nbd.2020.105089_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1523\/JNEUROSCI.1483-17.2017","article-title":"Locus coeruleus ablation exacerbates cognitive deficits, neuropathology, and lethality in P301S tau transgenic mice","volume":"38","author":"Chalermpalanupap","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.105089_bb0045","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/acn3.57","article-title":"beta1-adrenergic receptor activation enhances memory in Alzheimer's disease model","volume":"1","author":"Coutellier","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2020.105089_bb0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2020.105089_bb0055","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3233\/JAD-2010-091552","article-title":"Antihypertensive treatments, cognitive decline, and dementia","volume":"20","author":"Duron","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.105089_bb0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-5728(95)00080-L","article-title":"Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice","volume":"61","author":"Elenkov","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.105089_bb0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0031-6997(24)01470-4","article-title":"The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system","volume":"52","author":"Elenkov","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2020.105089_bb0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nbd.2011.04.011","article-title":"Comprehensive behavioral phenotyping of Ts65Dn mouse model of down syndrome: activation of beta1-adrenergic receptor by xamoterol as a potential cognitive enhancer","volume":"43","author":"Faizi","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.105089_bb0075","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/brb3.41","article-title":"Thy1-hAPP(Lond\/Swe+) mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function","volume":"2","author":"Faizi","year":"2012","journal-title":"Brain Behav."},{"key":"10.1016\/j.nbd.2020.105089_bb0080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0197-0186(02)00049-9","article-title":"Noradrenergic regulation of inflammatory gene expression in brain","volume":"41","author":"Feinstein","year":"2002","journal-title":"Neurochem. Int."},{"issue":"Suppl. 2","key":"10.1016\/j.nbd.2020.105089_bb0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jnc.13447","article-title":"Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system","volume":"139","author":"Feinstein","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.105089_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1533317506295889","article-title":"The influence of beta-blockers on delayed memory function in people with cognitive impairment","volume":"22","author":"Gliebus","year":"2007","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"key":"10.1016\/j.nbd.2020.105089_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0169-328X(95)00242-K","article-title":"Adrenalectomy enhances pro-inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide","volume":"36","author":"Goujon","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2020.105089_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/gerona\/60.1.67","article-title":"Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population","volume":"60","author":"Hajjar","year":"2005","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.nbd.2020.105089_bb0105","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1523\/JNEUROSCI.4236-05.2006","article-title":"Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice","volume":"26","author":"Heneka","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.105089_bb0110","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1073\/pnas.0909586107","article-title":"Locus ceruleus controls Alzheimer\u2019s disease pathology by modulating microglial functions through norepinephrine","volume":"107","author":"Heneka","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105089_bb0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/brbi.2001.0638","article-title":"Prior stressor exposure sensitizes LPS-induced cytokine production","volume":"16","author":"Johnson","year":"2002","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2020.105089_bb0120","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbi.2008.03.007","article-title":"Role of central beta-adrenergic receptors in regulating proinflammatory cytokine responses to a peripheral bacterial challenge","volume":"22","author":"Johnson","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2020.105089_bb0125","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.neurobiolaging.2006.06.003","article-title":"Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer\u2019s disease","volume":"28","author":"Kalinin","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.105089_bb0130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2567.2007.02781.x","article-title":"Beta2-adrenergic receptor regulates Toll-like receptor-4-induced nuclear factor-kappaB activation through beta-arrestin 2","volume":"124","author":"Kizaki","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.nbd.2020.105089_bb0135","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.tics.2016.01.001","article-title":"The locus coeruleus: essential for maintaining cognitive function and the aging brain","volume":"20","author":"Mather","year":"2016","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.nbd.2020.105089_bb0140","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbi.2010.02.005","article-title":"Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration","volume":"24","author":"McNamee","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2020.105089_bb0145","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1126\/science.aaf3934","article-title":"beta2-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson's disease","volume":"357","author":"Mittal","year":"2017","journal-title":"Science."},{"key":"10.1016\/j.nbd.2020.105089_bb0150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-140036","article-title":"Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of Tau, Inflammatory Changes, Cholinergic Degeneration, And Cognitive deficits in AbetaPPL\/S transgenic mice","volume":"42","author":"Nguyen","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2020.105089_bb0155","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1017\/S0033291799008703","article-title":"Stimulation of the noradrenergic system enhances and blockade reduces memory for emotional material in man","volume":"29","author":"O\u2019Carroll","year":"1999","journal-title":"Psychol. Med."},{"key":"10.1016\/j.nbd.2020.105089_bb0160","first-page":"1069","article-title":"Adrenergic effect on cytokine release after ex vivo healthy Volunteers\u2019 whole blood LPS stimulation","volume":"39","author":"Papandreou","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.nbd.2020.105089_bb0165","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MJT.0b013e3181bf325c","article-title":"Cognitive function and antihypertensive treatment in the elderly: a 6-year follow-up study","volume":"17","author":"Paran","year":"2010","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.nbd.2020.105089_bb2010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"7","author":"Perry","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.nbd.2020.105089_bb2000","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia."},{"key":"10.1016\/j.nbd.2020.105089_bb0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jneuroim.2010.10.001","article-title":"Complementary anti-inflammatory actions of the beta(2)-adrenoceptor agonist clenbuterol and the glucocorticoid dexamethasone in rat brain","volume":"232","author":"Ryan","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.105089_bb0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbi.2016.02.023","article-title":"Clenbuterol activates the central IL-1 system via the beta2-adrenoceptor without provoking inflammatory response related behaviours in rats","volume":"56","author":"Ryan","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2020.105089_bb0180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrn2573","article-title":"The locus coeruleus and noradrenergic modulation of cognition","volume":"10","author":"Sara","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2020.105089_bb0185","doi-asserted-by":"crossref","first-page":"17501","DOI":"10.1073\/pnas.0607207103","article-title":"Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus","volume":"103","author":"Saxe","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105089_bb0190","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2020.105089_bb2005","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s12035-018-1235-1","article-title":"Loss of brain norepinephrine elicits neuroinflammation-mediated oxidative injury and selective caudo-rostral neurodegeneration","volume":"56","author":"Song","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2020.105089_bb0195","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/iai.62.5.2046-2050.1994","article-title":"Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood","volume":"62","author":"van der Poll","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.nbd.2020.105089_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.05.004","article-title":"Carvedilol as a potential novel agent for the treatment of Alzheimer\u2019s disease","volume":"32","author":"Wang","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.105089_bb0205","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41467-017-01855-z","article-title":"Galphai is required for carvedilol-induced beta1 adrenergic receptor beta-arrestin biased signaling","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2020.105089_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00031305.2019.1583913","article-title":"Moving to a world beyond \u201cp < 0.05\u201d","volume":"73","author":"Wasserstein","year":"2019","journal-title":"Am. Stat."},{"key":"10.1016\/j.nbd.2020.105089_bb0215","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/156720508784533286","article-title":"Functional consequences of locus coeruleus degeneration in Alzheimer\u2019s disease","volume":"5","author":"Weinshenker","year":"2008","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.nbd.2020.105089_bb0220","doi-asserted-by":"crossref","first-page":"16657","DOI":"10.1073\/pnas.0707936104","article-title":"A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling","volume":"104","author":"Wisler","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105089_bb0225","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.psyneuen.2012.02.003","article-title":"Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice","volume":"37","author":"Wohleb","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.nbd.2020.105089_bb0230","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.expneurol.2012.05.008","article-title":"Norepinephrine differentially modulates the innate inflammatory response provoked by amyloid-beta peptide via action at beta-adrenoceptors and activation of cAMP\/PKA pathway in human THP-1 macrophages","volume":"236","author":"Yang","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.105089_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180319","article-title":"Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders","volume":"12","author":"Yi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.105089_bb0240","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120303648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120303648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:21:51Z","timestamp":1760851311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120303648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":51,"alternative-id":["S0969996120303648"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.105089","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.105089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105089"}}